A new trading day began on Friday, with Jasper Therapeutics Inc (NASDAQ: JSPR) stock price down -9.04% from the previous day of trading, before settling in for the closing price of $1.66. JSPR’s price has ranged from $1.39 to $7.43 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 54.53%. Meanwhile, its annual earnings per share averaged 14.93%. With a float of $23.87 million, this company’s outstanding shares have now reached $27.98 million.
Jasper Therapeutics Inc (JSPR) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Jasper Therapeutics Inc is 14.71%, while institutional ownership is 59.97%. The most recent insider transaction that took place on Sep 22 ’25, was worth 99,630. In this transaction Director of this company bought 41,000 shares at a rate of $2.43, taking the stock ownership to the 41,000 shares. Before that another transaction happened on Sep 22 ’25, when Company’s Director bought 20,000 for $2.43, making the entire transaction worth $48,600. This insider now owns 20,000 shares in total.
Jasper Therapeutics Inc (JSPR) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -1.62 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.68 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.42% during the next five years compared to 54.53% growth over the previous five years of trading.
Jasper Therapeutics Inc (NASDAQ: JSPR) Trading Performance Indicators
Here are Jasper Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.90, a number that is poised to hit -0.67 in the next quarter and is forecasted to reach -2.36 in one year’s time.
